4,356 Shares in Agilent Technologies, Inc. $A Acquired by Optiver Holding B.V.

Optiver Holding B.V. acquired a new stake in Agilent Technologies, Inc. (NYSE:A) in the first quarter, according to its most recent filing with the SEC. The fund acquired 4,356 shares of the medical research company’s stock, valued at approximately $496,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of A. Norges Bank bought a new position in shares of Agilent Technologies in the fourth quarter worth $549,158,000. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. AQR Capital Management LLC lifted its holdings in Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after purchasing an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its stake in Agilent Technologies by 192.0% in the 4th quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock worth $192,204,000 after purchasing an additional 928,821 shares during the period.

Agilent Technologies Stock Down 0.3%

A opened at $138.32 on Friday. The business’s fifty day simple moving average is $132.35 and its 200 day simple moving average is $125.30. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $39.06 billion, a PE ratio of 27.77, a P/E/G ratio of 2.46 and a beta of 1.25.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the previous year, the company posted $1.31 earnings per share. The company’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were given a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 20.48%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Royal Bank Of Canada started coverage on Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price for the company. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective for the company. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Finally, Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $159.35.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.